Literature DB >> 1289351

A beta-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxydans isolated from a case of meningitis.

D Decré1, G Arlet, C Danglot, J C Lucet, G Fournier, E Bergogne-Bérézin, A Philippon.   

Abstract

A resistant (R) clinical isolate of Alcaligenes denitrificans subsp. xylosoxydans was recovered from CSF during treatment including piperacillin. This variant selected in vivo, and a second variant obtained in vitro from the initially susceptible (S) strain, both exhibited resistance to penicillins (ticarcillin, piperacillin) and cephalosporins, but remained susceptible to latamoxef and imipenem. Clavulanate (2 mg/L) restored the susceptibility of the two R-variants to penicillins. A beta-lactamase of pI 9.5 was detected in both S and R strains, but overproduction was observed only in the in-vivo and in-vitro R-variants. This inducible beta-lactamase hydrolysed benzylpenicillin, cephalothin and cephaloridine efficiently, but amoxycillin, ticarcillin and cefoperazone were only moderate substrates. The enzyme was inhibited by clavulanate, cloxacillin and imipenem (IC50 between 3 and 9 mM), but not by aztreonam and chloride ions (1 mM). Resistance to beta-lactams was not transferable by conjugation to Escherichia coli or Pseudomonas aeruginosa, and DNA agarose gel electrophoresis indicated that no plasmid was present in the isolates. Restriction patterns of chromosomal DNA isolated from the S and R isolates were similar after digestion by NotI and HindIII.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289351     DOI: 10.1093/jac/30.6.769

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans.

Authors:  D Decré; G Arlet; E Bergogne-Bérézin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

4.  Identification of alcaligin as the siderophore produced by Bordetella pertussis and B. bronchiseptica.

Authors:  C H Moore; L A Foster; D G Gerbig; D W Dyer; B W Gibson
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

5.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status.

Authors:  William G Branton; Kristofor K Ellestad; Ferdinand Maingat; B Matt Wheatley; Erling Rud; René L Warren; Robert A Holt; Michael G Surette; Christopher Power
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

7.  Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.

Authors:  Tim Holm Jakobsen; Martin Asser Hansen; Peter Østrup Jensen; Lars Hansen; Leise Riber; April Cockburn; Mette Kolpen; Christine Rønne Hansen; Winnie Ridderberg; Steffen Eickhardt; Marlene Hansen; Peter Kerpedjiev; Morten Alhede; Klaus Qvortrup; Mette Burmølle; Claus Moser; Michael Kühl; Oana Ciofu; Michael Givskov; Søren J Sørensen; Niels Høiby; Thomas Bjarnsholt
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

8.  Successful treatment of multiresistant Achromobacter xylosoxidans bacteremia in a child with acute myeloid leukemia.

Authors:  Deniz Tugcu; Ozden Turel; Gonul Aydogan; Arzu Akcay; Zafer Salcioglu; Ferhan Akici; Hulya Sen; Metin Demirkaya; Necati Taskin; Nezahat Gurler
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

Review 9.  Microbiology of Cystic Fibrosis Airway Disease.

Authors:  Ana C Blanchard; Valerie J Waters
Journal:  Semin Respir Crit Care Med       Date:  2019-12-30       Impact factor: 3.119

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.